Bayesian analysis of population PK/PD models: General concepts and software

Journal of Pharmacokinetics and Pharmacodynamics

Volumn 29, Issue 3, 2002, Pages 271-307

  Lunn, D J ^a   Best, N ^a   Thomas, A ^a   Wakefield, J ^b   Spiegelhalter, D ^c  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Bayesian hierarchical models; BUGS; Gibbs sampling; Markov chain Monte Carlo; PKBugs; Population analysis; WinBUGS

Indexed keywords

ARTICLE; BAYES THEOREM; COMPUTER PROGRAM; DATA ANALYSIS; MODEL; MONTE CARLO METHOD; MUCOSA ASSOCIATED LYMPHOID TISSUE LYMPHOMA; PHARMACODYNAMICS; PHARMACOKINETICS; POPULATION; PRIORITY JOURNAL; STATISTICAL ANALYSIS; TECHNIQUE;

BAYES THEOREM; MODELS, BIOLOGICAL; SOFTWARE;

EID: 0036428867     PISSN: 1567567X     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1020206907668     Document Type: Article

References (49)

1. N. G. Best, D. J. Spiegelhalter, A. Thomas, and C. E. G. Brayne. Bayesian analysis of realistically complex models, J. R. Statist. Soc. A 159:323-342 (1996).
2. A. Gelman, J. B. Carlin, H. S. Stern, and D. B. Rubin. Bayesian Data Analysis, Chapman and Hall, London (1995).
3. W. R. Gilks, S. Richardson, and D. J. Spiegelhalter. Markov Chain Monte Carlo in Practice, Chapman and Hall, London (1996).
4. H. S. Migon and D. Gamerman. Statistical Inference: An Integrated Approach, Arnold, London (1999).
5. N. G. Best, K. K. C. Tan, W. R. Gilks, and D. J. Spiegelhalter. Estimation of population pharmacokinetics using the Gibbs sampler, J. Pharmacokin. Biopharm. 23:407-435 (1995).
6. P. Spector, An Introduction to S and S-PLUS, Duxbury Press, Belmont, CA (1994).
7. D. Spiegelhalter, A. Thomas, and N. Best, WinBUGS Version 1.3 User Manual, Medical Research Council Biostatistics Unit, Cambridge (2000).
8. J. Rasbash et al. A User's Guide to MLwiN (Second Edition), Institute of Education, London (2000).
9. S. L. Beal and L. B. Sheiner. NONMEM User's Guide, parts I-VII, NONMEM Project Group, San Francisco (1992).
10. M. O. Karlsson and L. B. Sheiner. The importance of modeling inter-occasion variability in population pharmacokinetic analyses, J. Pharmacokin. Biopharm. 21:735-750 (1993).
11. D. J. Lunn and L. J. Aarons. Markov chain Monte Carlo techniques for studying inter-occasion and intersubject variability: Application to pharmacokinetic data, Appl. Statist. 46:73-91 (1997).
12. J. C. Wakefield, A. F. M. Smith, A. Racine-Poon, and A. E. Gelfand. Basyesian analysis of linear and non-linear population models by using the Gibbs sampler, Appl. Statist. 43:201-221 (1994).
13. D. J. Spiegelhalter, N. G. Best, and B. P. Carlin. Bayesian deviance, the effective number of parameters, and the comparison of arbitrarily complex models, Technical Report, Medical Research Council Biostatistics Unit, Cambridge (1998).
14. A. E. Gelfand and M. Trevisani. Inequalities between expected marginal log likelihoods with implications for likelihood-based model comparison, Technical Report tr0038, Dept. of Statistics, University of Connecticut (2000).
15. S. L. Lauritzen, A. P. Dawid, B. N. Larsen, and H. G. Leimer. Independence properties of directed Markov fields, Networks 20:491-505 (1990).
16. J. Whittaker. Graphical Models in Applied Multivariate Analysis, John Wiley and Sons, Chichester (1990).
17. D. J. Spiegelhalter, A. P. Dawid, S. L. Lauritzen, and R. G. Cowell. Bayesian analysis in expert systems (with discussion), Statistical Science 8:219-283 (1993).
18. D. J. Lunn, A. Thomas, N. Best, and D. Spiegelhalter. WinBUGS - A Bayesian modeling framework: Concepts, structure, and extensibility, Statistics and Computing 10:325-337 (2000).
19. G. R. Grimmett and D. R. Stirzaker. Probability and Random Processes, 2nd Edition, Oxford University Press, New York (1992).
20. S. Geman and D. Geman. Stochastic relaxation, Gibbs distributions and the Bayesian restoration of images, IEEE Trans. Pattn. Anal. Mach. Intell. 6:721-741 (1984).
21. A. E. Gelfand and A. F. M. Smith. Sampling-based approaches to calculating marginal densities, J. Am. Statist. Ass. 85:398-409 (1990).
22. N. Metropolis, A. W. Rosenbluth, M. N. Rosenbluth, A. H. Teller, and E. Teller. Equations of state calculations by fast computing machines, J. Chem. Phys. 21:1087-1091 (1953).
23. W. K. Hastings. Monte Carlo sampling-based methods using Markov chains and their applications, Biometrika 57:97-109 (1970).
24. W. R. Gilks. Full conditional distributions. In W. R. Gilks, S. Richardson, and D. J. Spiegelhalter (eds.), Markov Chain Monte Carlo in Practice, Chapman and Hall, London, 1996, pp. 75-88.
25. B. D. Ripley. Stochastic Simulation, John Wiley and Sons, New York (1987).
26. W. R. Gilks and P. Wild. Adapative rejection sampling for Gibbs sampling, Applied Statistics 41:337-348 (1992).
27. W. Gilks, Derivative-free adaptive rejection sampling for Gibbs sampling. In: J. M. Bernardo, J. O. Berger, A. P. Dawid, and A. F. M. Smith (eds.), Bayesian Statistics 4, Oxford University Press, Oxford, 1992, pp. 641-665.
28. R. M. Neal. Markov chain Monte Carlo methods based on "slicing" the density function, Technical Report 9722, Dept. of Statistics, University of Toronto (1997).
29. R. Natarajan and R. E. Kass. Reference Bayesian methods for generalized linear mixed models, J. Am. Statist. Ass. 95:227-237 (2000).
30. M. K. Cowles and B. P. Carlin. Markov chain Monte Carlo convergence diagnostics: A comparative review, J. Am. Statist. Ass. 91:883-904 (1996).
31. K. L. Mengersen, C. P. Robert, and C. Guihenneuc-Jouyaux. MCMC convergence diagnostics: A review, in Bayesian Statistics 6, J. M. Bernardo, J. O. Berger, A. P. Dawid, and A. F. M. Smith (eds.), pp. 415-440, Oxford University Press, Oxford (1999).
32. N. G. Best, M. K. Cowles, and S. K. Vines. CODA: Convergence Diagnosis and Output Analysis Software for Gibbs Sampler Output: Version 0.3, Medical Research Council Biostatistics Unit, Cambridge (1995).
33. B. J. Smith. Bayesian Output Analysis Program (BOA) Version 0.5.0 User Manual, Department of Biostatistics, University of Iowa College of Public Health, Iowa City (2000).
34. A. Gelman and D. B. Rubin. Inference from iterative simulation using multiple sequences (with discussion), Statistical Science 7:457-511 (1992).
35. S. P. Brooks and A. Gelman. Alternative methods for monitoring convergence of iterative simulations. J. Comput. Graph. Stat. 7, 434-455 (1998).
36. S. L. Beal. Ways to fit a PK model with some data below the quantification limit, J. Pharmacokin. Pharmacodyn. 28, 481-504 (2001).
37. J. C. Wakefield. An expected loss approach to the design of dosage regimens via sampling-based methods, The Statistician 43:13-29 (1994).
38. H. Akaike. A new look at statistical model identification, IEEE Trans. Auto. Cont. AU-19:716-722 (1974).
39. P. J. Green. Reversible jump Markov chain Monte Carlo computation and Bayesian model determination, Biometrika 82:711-732 (1995).
40. A. H. Thomson, S. Way, S. M. Bryson, E. M. McGovern, A. W. Kelman, and B. Whiting. Population pharmacokinetics of gentamicin in neonates, Dev. Pharm. Therapeutics 11:173-179 (1988).
41. R. M. Neal. Suppressing random walks in Markov chain Monte Carlo using ordered over-relaxation. In M. I. Jordan (ed.), Learning in Graphical Models, Kluwer Academic Publishers, Dordrecht, 1998, pp. 205-225.
42. D. J. Lunn and L. Aarons. The pharmacokinetics of saquinavir: A Markov chain Monte Carlo population analysis, J. Pharmacokin. Biopharm. 26:47-74 (1998).
43. J. Besag, P. J. Green, D. Higdon, and K. Mengersen, Bayesian computation and stochastic systems (with discussion), Statistical Science 10:3-66 (1995).
44. D. J. Lunn, J. Wakefield, A. Thomas, N. Best, and D. Spiegelhalter, PKBugs User Guide Version 1.1, Dept. Epidemiology and Public Health, Imperial College School of Medicine, London (1999).
45. P. Diggle and M. G. Kenward. Informative drop-out in longitudinal data analysis (with discussion), Appl. Statist. 43:49-93 (1994).
46. L. B. Sheiner, S. L. Beal, and A. Dunne, Analysis of nonrandomly censored ordered categorical longitudinal data from analgesic trials, J. Am. Statist. Ass. 92:1235-1244 (1997).
47. J. Richard, J. M. Cardot, and J. Godbillon. Inter- and intra-subject variability of metoprolol kinetics after intravenous administration, Eur. J. Drug Metab. Pharmakinet. 19, 157-162 (1994).
48. J. E. Bennett and J. C. Wakefield. A comparison of a Bayesian population method with two methods as implemented in commercially available software, J. Pharmacokin. Biopharm. 24:403-432 (1996).
49. L. Aarons. Software for population pharmacokinetics and pharmacodynamics, Clin. Pharmacokin. 36:255-264 (1999).